bioMérieux reports 8% organic Q3 sales growth and maintains 2026 guidance

Q3 sales were €1.042 billion and organic growth was 8%. Nine-month sales were €3.006 billion and organic growth was 2.7%.

Organic growth is a company-defined comparison that removes specified currency and perimeter effects; it is not reported revenue growth. GO•28 drivers grew 13% in Q3.

Respiratory-panel sales fell 14% over nine months. Maintaining 2026 guidance is not a new reported result.

Read the official primary record. Sources checked 2026-11-03T09:36:05.655Z.

AI-assisted reporting checked against official primary records; not personalised investment advice. The image is a CapKet original conceptual illustration and does not depict an actual issuer facility or event.

Recorded source observation: 3 Nov 2026, 15:06:05 IST. This is a source-check timestamp, not a market quote or a new article update.